Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

INSM | Insmed Inc

IndexRUT P/E- EPS (ttm)-5.24 Insider Own2.91% Shs Outstand143.80M Perf Week-3.19%
Market Cap3.67B Forward P/E- EPS next Y-4.59 Insider Trans-1.07% Shs Float139.62M Perf Month18.00%
Income-695.84M PEG- EPS next Q-1.13 Inst Own101.75% Short Float / Ratio9.80% / 10.36 Perf Quarter25.49%
Sales269.47M P/S13.61 EPS this Y-33.37% Inst Trans-4.60% Short Interest13.68M Perf Half Y48.77%
Book/sh-1.09 P/B- EPS next Y11.89% ROA-55.83% Target Price40.77 Perf Year19.33%
Cash/sh6.38 P/C4.00 EPS next 5Y- ROE-1453.41% 52W Range16.04 - 27.59 Perf YTD27.63%
Dividend- P/FCF- EPS past 5Y-6.25% ROI-59.10% 52W High-7.58% Beta1.47
Dividend %- Quick Ratio4.77 Sales past 5Y270.57% Gross Margin76.99% 52W Low58.98% ATR0.88
Employees736 Current Ratio5.15 Sales Q/Q18.41% Oper. Margin-243.22% RSI (14)55.07 Volatility3.48% 3.63%
OptionableYes Debt/Eq- EPS Q/Q-122.55% Profit Margin-258.22% Rel Volume0.48 Prev Close25.90
ShortableYes LT Debt/Eq- EarningsAug 03 BMO Payout- Avg Volume1.32M Price25.50
Recom1.08 SMA20-0.70% SMA509.50% SMA20025.57% Volume414,589 Change-1.54%
Date Action Analyst Rating Change Price Target Change
Jul-26-23Initiated Guggenheim Buy $50
Dec-09-22Initiated Mizuho Buy $28
Dec-07-22Initiated Barclays Overweight $37
Nov-18-22Initiated BofA Securities Buy $39
Apr-27-22Initiated Goldman Buy $56
Dec-06-21Initiated JP Morgan Overweight $45
Oct-19-21Resumed Morgan Stanley Overweight $56 → $52
Oct-19-21Resumed Monness Crespi & Hardt Buy $52
Oct-08-21Initiated Cantor Fitzgerald Overweight $60
Apr-26-21Resumed Credit Suisse Outperform $60
Sep-26-23 08:00AM
Sep-08-23 02:09PM
08:00AM
Sep-06-23 08:00AM
07:46AM
07:32PM Loading…
Sep-05-23 07:32PM
04:10PM
12:18PM
11:52AM
07:00AM
Aug-04-23 08:00AM
Aug-03-23 09:05AM
07:55AM
07:30AM
Jul-20-23 08:00AM
08:00AM Loading…
Jul-07-23 08:00AM
Jun-30-23 06:14AM
Jun-07-23 08:00AM
Jun-06-23 08:00AM
May-22-23 04:05PM
May-08-23 07:30AM
May-05-23 08:00AM
May-04-23 08:55AM
07:50AM
07:30AM
May-02-23 10:01AM
Apr-27-23 10:03AM
Apr-24-23 08:00AM
Apr-20-23 08:00AM
Apr-18-23 06:34AM
08:00AM Loading…
Apr-06-23 08:00AM
Mar-31-23 08:00AM
Mar-24-23 04:22PM
Mar-23-23 06:51AM
Mar-21-23 05:10PM
Mar-03-23 08:00AM
Mar-01-23 08:00AM
Feb-24-23 05:42AM
Feb-23-23 09:15AM
07:30AM
Feb-19-23 07:49AM
Feb-16-23 10:01AM
Feb-09-23 10:01AM
08:00AM
Feb-07-23 08:00AM
Feb-03-23 08:00AM
Jan-26-23 10:45AM
Jan-24-23 09:55AM
Jan-20-23 08:00AM
Jan-19-23 05:48AM
Jan-06-23 08:00AM
Jan-03-23 08:00AM
Dec-06-22 08:00AM
Nov-30-22 08:00AM
Nov-04-22 08:00AM
Nov-03-22 08:26PM
Nov-01-22 08:00AM
Oct-27-22 04:05PM
08:45AM
07:30AM
Oct-25-22 10:01AM
Oct-20-22 10:01AM
Oct-19-22 05:14PM
08:50AM
Oct-13-22 08:00AM
Oct-07-22 08:00AM
Oct-06-22 08:00AM
Oct-04-22 12:00PM
Sep-22-22 01:31AM
Sep-18-22 09:55AM
Sep-07-22 08:00AM
Sep-06-22 08:00AM
Aug-08-22 01:23PM
Aug-05-22 08:00AM
Aug-04-22 09:35AM
07:30AM
Aug-01-22 10:00AM
Jul-28-22 10:03AM
Jul-21-22 08:00AM
Jul-08-22 08:00AM
Jun-09-22 09:42AM
Jun-03-22 08:00AM
May-23-22 08:00AM
May-17-22 06:05PM
08:00AM
May-15-22 08:52AM
May-06-22 08:00AM
May-05-22 09:05AM
07:30AM
May-04-22 09:10PM
Apr-28-22 03:02PM
Apr-21-22 08:00AM
Apr-07-22 08:00AM
Mar-28-22 08:00AM
Mar-04-22 08:00AM
Mar-03-22 08:00AM
Feb-17-22 08:25AM
07:00AM
Feb-10-22 03:01PM
08:00AM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Michael AlexanderGeneral Counsel, Senior VPJul 11Sale20.1874014,93377,142Jul 13 04:01 PM
Adsett RogerChief Operating OfficerJun 13Sale19.328,981173,513151,352Jun 15 04:05 PM
Flammer Martina M.D.Chief Medical OfficerJun 13Sale19.278,868170,886106,038Jun 15 04:06 PM
Wise John DraytonChief Commercial OfficerMay 25Sale18.953,36663,786102,681May 26 04:05 PM
Lewis WilliamChair and CEOMay 17Sale18.127,099128,634341,345May 17 04:11 PM
Adsett RogerChief Operating OfficerMay 17Sale18.122,44844,358160,333May 17 04:07 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 17Sale18.161,97235,81293,525May 17 04:13 PM
Wise John DraytonChief Commercial OfficerMay 17Sale18.171,91334,759106,047May 17 04:16 PM
Smith Michael AlexanderGeneral Counsel, Senior VPMay 17Sale18.181,26322,96177,082May 17 04:14 PM
Lewis WilliamChair and CEOMay 16Sale18.413,71468,375348,444May 17 04:11 PM
Flammer Martina M.D.Chief Medical OfficerMay 16Sale18.431,71831,663114,906May 17 04:10 PM
Bonstein SaraChief Financial OfficerMay 16Sale18.471,61029,737117,619May 17 04:09 PM
Adsett RogerChief Operating OfficerMay 16Sale18.391,52127,971162,781May 17 04:07 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 16Sale18.451,21722,45495,497May 17 04:13 PM
Smith Michael AlexanderGeneral Counsel, Senior VPMay 16Sale18.434758,75478,345May 17 04:14 PM
Wise John DraytonChief Commercial OfficerMay 16Sale18.443817,026107,960May 17 04:16 PM
SHAROKY MELVIN MDDirectorMay 15Buy19.2910,000192,90010,000May 17 04:06 PM
SHAROKY MELVIN MDDirectorMay 15Buy19.2910,000192,900298,615May 17 04:06 PM
Lewis WilliamChair and CEOMay 15Sale19.236,048116,303352,158May 17 04:11 PM
Adsett RogerChief Operating OfficerMay 15Sale19.272,84754,862164,302May 17 04:07 PM
Flammer Martina M.D.Chief Medical OfficerMay 15Sale19.282,57649,665116,624May 17 04:10 PM
Bonstein SaraChief Financial OfficerMay 15Sale19.302,21042,653119,229May 17 04:09 PM
Smith Michael AlexanderGeneral Counsel, Senior VPMay 15Sale19.241,89736,49878,820May 17 04:14 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 15Sale19.221,83035,17396,714May 17 04:13 PM
Wise John DraytonChief Commercial OfficerMay 15Sale19.2959311,439108,341May 17 04:16 PM
Lewis WilliamChair and CEOMay 12Option Exercise12.44233,9242,910,015233,924May 15 04:12 PM
Lewis WilliamChair and CEOJan 10Sale18.006,994125,892265,067Jan 12 04:10 PM
Flammer Martina M.D.Chief Medical OfficerJan 10Sale18.063,43962,10872,763Jan 12 04:09 PM
Adsett RogerChief Operating OfficerJan 10Sale17.993,19457,460135,487Jan 12 04:06 PM
Bonstein SaraChief Financial OfficerJan 10Sale18.122,85751,76966,031Jan 12 04:08 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 10Sale17.952,43543,70872,159Jan 12 04:11 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 10Sale17.931,83632,91954,332Jan 12 04:13 PM
Wise John DraytonChief Commercial OfficerJan 10Sale17.9677913,99177,272Jan 12 04:14 PM
Lewis WilliamChair and CEOJan 05Sale19.807,008138,758249,708Jan 06 04:24 PM
Adsett RogerChief Operating OfficerJan 05Sale19.753,04460,119131,083Jan 06 04:08 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 05Sale19.731,44828,56968,262Jan 06 04:27 PM
Flammer Martina M.D.Chief Medical OfficerJan 05Sale19.731,37427,10965,058Jan 06 04:22 PM
Wise John DraytonChief Commercial OfficerJan 05Sale19.741,16022,89870,453Jan 06 04:30 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 05Sale19.7272014,19849,836Jan 06 04:29 PM
Adsett RogerChief Operating OfficerNov 22Sale18.8011,855222,874134,127Nov 22 05:03 PM
Wise John DraytonChief Commercial OfficerNov 22Sale18.847,154134,78171,613Nov 22 05:05 PM
SHAROKY MELVIN MDDirectorNov 01Buy17.7010,000177,00015,900Nov 02 04:23 PM
LEE LEODirectorOct 31Buy17.6945,000796,05098,265Nov 02 04:20 PM
SHAROKY MELVIN MDDirectorOct 31Buy17.5320,000350,600281,021Nov 02 04:23 PM